证券代码：301267 证券简称：华厦眼科 投资者关系活动记录表 公司已在国内初步选定 24 个重点投资省份，将通过自建 或并购方式建设眼科医疗服务网络，具体执行情况将综合行业 环境、市场情况及公司经营需要等因素适当调整，稳健推进。 未来自建和并购眼科医院将同步进行，公司将综合考虑所在城 市是否具备符合条件的优质标的及专家团队的组建情况进行 科学审慎决策。 4、目前公司各项业务的收入结构及未来的发展规划？ 2025 年上半年，公司屈光业务收入占比为 36.90%，眼视 光综合业务收入占比为 24.04%，白内障业务收入占比为 20.14%，眼后段业务收入占比为 12.94%。未来，公司将继续 坚持"眼病诊疗+消费眼科"双轮驱动战略，围绕全科诊疗服 务体系，推动各项业务均衡发展。 华厦眼科医院集团股份有限公司 编号：2025-004 | | 特定对象调研 □分析师会议 | | --- | --- | | | □媒体采访 □业绩说明会 | | 投资者关系活动类别 | □新闻发布会 □路演活动 | | | ☑现场参观 | | | □其他： 惠璞投资：徐克 | | | 天风资管：许磊涛 | | 参与单位名称及人员 ...

Financial Performance - In 2024, the company achieved operating revenue of CNY 4.027 billion, a year-on-year increase of 0.35% [2] - The net profit attributable to shareholders was CNY 429 million, a decrease of 35.63% [2] - As of the end of the reporting period, total assets amounted to CNY 7.924 billion, with net assets of CNY 5.794 billion [3] - In Q1 2025, operating revenue reached CNY 1.093 billion, a year-on-year growth of 11.74%, while net profit was CNY 150 million, down 4.00% [3] Business Segment Performance - In 2024, the cataract business generated revenue of CNY 873 million, a decline of 11.56% due to the implementation of centralized procurement policies [3] - The refractive business achieved revenue of CNY 1.296 billion, growing by 7.44% [3] - The comprehensive optometry business reported revenue of CNY 1.069 billion, an increase of 5.15% [3] - The eye posterior segment business saw revenue of CNY 536 million, a slight increase of 0.19% [3] Market Outlook - The aging population is expected to drive demand for various age-related eye diseases, including cataracts, with an estimated 80% incidence rate among individuals over 60 [8] - By 2050, the number of cataract patients in China is projected to reach 241 million [8] - The prevalence of myopia among children and adolescents is a significant public health issue, with a reported rate of 51.9% in 2022 [9] - The market for eye care services in China is anticipated to grow, driven by increasing demand in various segments [9] Strategic Initiatives - The company plans to expand its operations through mergers and acquisitions or self-built facilities in 24 key investment provinces [10] - There is a focus on enhancing the eye care service network and improving operational efficiency through technology and management systems [7] - The company is actively seeking overseas expansion opportunities, particularly in Europe and Asia, to enhance its global footprint [11]